Literature DB >> 20203293

Transient receptor potential canonical channel 6 links Ca2+ mishandling to cystic fibrosis transmembrane conductance regulator channel dysfunction in cystic fibrosis.

Fabrice Antigny1, Caroline Norez, Luc Dannhoffer, Johanna Bertrand, Dorothée Raveau, Pierre Corbi, Christophe Jayle, Frédéric Becq, Clarisse Vandebrouck.   

Abstract

In cystic fibrosis (CF), abnormal control of cellular Ca(2+) homeostasis is observed. We hypothesized that transient receptor potential canonical (TRPC) channels could be a link between the abnormal Ca(2+) concentrations in CF cells and cystic fibrosis transmembrane conductance regulator (CFTR) dysfunction. We measured the TRPC and CFTR activities (using patch clamp and fluorescent probes) and interactions (using Western blotting and co-immunoprecipitation) in CF and non-CF human epithelial cells treated with specific and scrambled small interfering RNA (siRNA). The TRPC6-mediated Ca(2+) influx was abnormally increased in CF compared with non-CF cells. After correction of abnormal F508 deletion (del)-CFTR trafficking in CF cells, the level of TRPC6-dependent Ca(2+) influx was also normalized. In CF cells, siRNA-TRPC6 reduced this abnormal Ca(2+) influx. In non-CF cells, siRNA-TRPC6 reduced the Ca(2+) influx and activity wild-type (wt)-CFTR. Co-immunoprecipitation experiments revealed TRPC6/CFTR and TRPC6/F508 del-CFTR interactions in CF or non-CF epithelial cells. Although siRNA-CFTR reduced the activity of wt-CFTR in non-CF cells and of F508 del-CFTR in corrected CF cells, it also enhanced TRPC6-dependent Ca(2+) influx in non-CF cells, mimicking the results obtained in CF cells. Finally, this functional and reciprocal coupling between CFTR and TRPC6 was also detected in non-CF ciliated human epithelial cells freshly isolated from lung samples. These data indicate that TRPC6 and CFTR are functionally and reciprocally coupled within a molecular complex in airway epithelial human cells. Because this functional coupling is lost in CF cells, the TRPC6-dependent Ca(2+) influx is abnormal.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20203293     DOI: 10.1165/rcmb.2009-0347OC

Source DB:  PubMed          Journal:  Am J Respir Cell Mol Biol        ISSN: 1044-1549            Impact factor:   6.914


  23 in total

1.  Abnormal n-6 fatty acid metabolism in cystic fibrosis is caused by activation of AMP-activated protein kinase.

Authors:  Obi C Umunakwe; Adam C Seegmiller
Journal:  J Lipid Res       Date:  2014-05-24       Impact factor: 5.922

2.  CFTR and sphingolipids mediate hypoxic pulmonary vasoconstriction.

Authors:  Christoph Tabeling; Hanpo Yu; Liming Wang; Hannes Ranke; Neil M Goldenberg; Diana Zabini; Elena Noe; Adrienn Krauszman; Birgitt Gutbier; Jun Yin; Michael Schaefer; Christoph Arenz; Andreas C Hocke; Norbert Suttorp; Richard L Proia; Martin Witzenrath; Wolfgang M Kuebler
Journal:  Proc Natl Acad Sci U S A       Date:  2015-03-17       Impact factor: 11.205

Review 3.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

4.  Dysregulated Calcium Homeostasis in Cystic Fibrosis Neutrophils Leads to Deficient Antimicrobial Responses.

Authors:  Frank H Robledo-Avila; Juan de Dios Ruiz-Rosado; Kenneth L Brockman; Benjamin T Kopp; Amal O Amer; Karen McCoy; Lauren O Bakaletz; Santiago Partida-Sanchez
Journal:  J Immunol       Date:  2018-08-17       Impact factor: 5.422

5.  Enhanced Ca2+ entry due to Orai1 plasma membrane insertion increases IL-8 secretion by cystic fibrosis airways.

Authors:  Haouaria Balghi; Renaud Robert; Benjamin Rappaz; Xuexin Zhang; Adeline Wohlhuter-Haddad; Alexandra Evagelidis; Yishan Luo; Julie Goepp; Pasquale Ferraro; Philippe Roméo; Mohamed Trebak; Paul W Wiseman; David Y Thomas; John W Hanrahan
Journal:  FASEB J       Date:  2011-08-26       Impact factor: 5.191

6.  The impact of Cystic Fibrosis Transmembrane Regulator Disruption on cardiac function and stress response.

Authors:  Kai Jiang; Sen Jiao; Megan Vitko; Rebecca Darrah; Chris A Flask; Craig A Hodges; Xin Yu
Journal:  J Cyst Fibros       Date:  2015-06-25       Impact factor: 5.482

7.  Control the platelets, control the disease: A novel cystic fibrosis hypothesis.

Authors:  Siobhan Branfield; A Valance Washington
Journal:  J Thromb Haemost       Date:  2020-05-28       Impact factor: 5.824

8.  Defective goblet cell exocytosis contributes to murine cystic fibrosis-associated intestinal disease.

Authors:  Jinghua Liu; Nancy M Walker; Akifumi Ootani; Ashlee M Strubberg; Lane L Clarke
Journal:  J Clin Invest       Date:  2015-02-02       Impact factor: 14.808

Review 9.  Dysregulated Chemokine Signaling in Cystic Fibrosis Lung Disease: A Potential Therapeutic Target.

Authors:  Xiaoqing Guan; Yuning Hou; Fei Sun; Zhe Yang; Chunying Li
Journal:  Curr Drug Targets       Date:  2016       Impact factor: 3.465

10.  TRPC6 channel translocation into phagosomal membrane augments phagosomal function.

Authors:  Vladimir Riazanski; Aida G Gabdoulkhakova; Lin S Boynton; Raphael R Eguchi; Ludmila V Deriy; D Kyle Hogarth; Nadège Loaëc; Nassima Oumata; Hervé Galons; Mary E Brown; Pavel Shevchenko; Alexander J Gallan; Sang Gune Yoo; Anjaparavanda P Naren; Mitchel L Villereal; Daniel W Beacham; Vytautas P Bindokas; Lutz Birnbaumer; Laurent Meijer; Deborah J Nelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.